These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 23328431

  • 1. [Effects of modification of transferrin on cytotoxicity and intracellular delivery of paclitaxel loaded PLGA nanoparticles].
    Jin SH, Li NC, Zhang ZH, Na YQ.
    Zhonghua Yi Xue Za Zhi; 2012 Nov 27; 92(44):3151-4. PubMed ID: 23328431
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Paclitaxel-loaded PLGA nanoparticles surface modified with transferrin and Pluronic((R))P85, an in vitro cell line and in vivo biodistribution studies on rat model.
    Shah N, Chaudhari K, Dantuluri P, Murthy RS, Das S.
    J Drug Target; 2009 Aug 27; 17(7):533-42. PubMed ID: 19530913
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
    Liu R, Wang Y, Li X, Bao W, Xia G, Chen W, Cheng J, Xu Y, Guo L, Chen B.
    Drug Des Devel Ther; 2015 Aug 27; 9():2705-19. PubMed ID: 26045659
    [Abstract] [Full Text] [Related]

  • 5. Targeting nevirapine delivery across human brain microvascular endothelial cells using transferrin-grafted poly(lactide-co-glycolide) nanoparticles.
    Kuo YC, Lin PI, Wang CC.
    Nanomedicine (Lond); 2011 Aug 27; 6(6):1011-26. PubMed ID: 21707298
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Polydopamine-based surface modification for the development of peritumorally activatable nanoparticles.
    Gullotti E, Park J, Yeo Y.
    Pharm Res; 2013 Aug 27; 30(8):1956-67. PubMed ID: 23609560
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment.
    Cui Y, Xu Q, Chow PK, Wang D, Wang CH.
    Biomaterials; 2013 Nov 27; 34(33):8511-20. PubMed ID: 23932498
    [Abstract] [Full Text] [Related]

  • 12. Cytotoxicity of Paclitaxel in biodegradable self-assembled core-shell poly(lactide-co-glycolide ethylene oxide fumarate) nanoparticles.
    He X, Ma J, Mercado AE, Xu W, Jabbari E.
    Pharm Res; 2008 Jul 27; 25(7):1552-62. PubMed ID: 18196205
    [Abstract] [Full Text] [Related]

  • 13. Enhanced in vitro antiproliferative effects of EpCAM antibody-functionalized paclitaxel-loaded PLGA nanoparticles in retinoblastoma cells.
    Mitra M, Misra R, Harilal A, Sahoo SK, Krishnakumar S.
    Mol Vis; 2011 Jul 27; 17():2724-37. PubMed ID: 22065926
    [Abstract] [Full Text] [Related]

  • 14. Developing combination of artesunate with paclitaxel loaded into poly-d,l-lactic-co-glycolic acid nanoparticle for systemic delivery to exhibit synergic chemotherapeutic response.
    Tran BN, Nguyen HT, Kim JO, Yong CS, Nguyen CN.
    Drug Dev Ind Pharm; 2017 Dec 27; 43(12):1952-1962. PubMed ID: 28724314
    [Abstract] [Full Text] [Related]

  • 15. Effects of surfactants on the properties of PLGA nanoparticles.
    Menon JU, Kona S, Wadajkar AS, Desai F, Vadla A, Nguyen KT.
    J Biomed Mater Res A; 2012 Aug 27; 100(8):1998-2005. PubMed ID: 22566409
    [Abstract] [Full Text] [Related]

  • 16. Protein functionalized tramadol-loaded PLGA nanoparticles: preparation, optimization, stability and pharmacodynamic studies.
    Lalani J, Rathi M, Lalan M, Misra A.
    Drug Dev Ind Pharm; 2013 Jun 27; 39(6):854-64. PubMed ID: 22799442
    [Abstract] [Full Text] [Related]

  • 17. Anti-tumor activity of paclitaxel through dual-targeting carrier of cyclic RGD and transferrin conjugated hyperbranched copolymer nanoparticles.
    Xu Q, Liu Y, Su S, Li W, Chen C, Wu Y.
    Biomaterials; 2012 Feb 27; 33(5):1627-39. PubMed ID: 22118775
    [Abstract] [Full Text] [Related]

  • 18. Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation.
    Madani F, Esnaashari SS, Bergonzi MC, Webster TJ, Younes HM, Khosravani M, Adabi M.
    Life Sci; 2020 Sep 01; 256():117943. PubMed ID: 32531377
    [Abstract] [Full Text] [Related]

  • 19. Enhanced electrostatic interaction between chitosan-modified PLGA nanoparticle and tumor.
    Yang R, Shim WS, Cui FD, Cheng G, Han X, Jin QR, Kim DD, Chung SJ, Shim CK.
    Int J Pharm; 2009 Apr 17; 371(1-2):142-7. PubMed ID: 19118614
    [Abstract] [Full Text] [Related]

  • 20. Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention.
    Sahoo SK, Labhasetwar V.
    Mol Pharm; 2005 Apr 17; 2(5):373-83. PubMed ID: 16196490
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.